Suzanne Sawochka Hooper

2014

In 2014, Suzanne Sawochka Hooper earned a total compensation of $3.7M as Executive Vice President and GC at Jazz Pharmaceuticals, a 33% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$320,000
Option Awards$1,271,046
Salary$483,462
Stock Awards$1,666,199
Other$3,710
Total$3,744,417

Hooper received $1.7M in stock awards, accounting for 44% of the total pay in 2014.

Hooper also received $320K in non-equity incentive plan, $1.3M in option awards, $483.5K in salary and $3.7K in other compensation.

Rankings

In 2014, Suzanne Sawochka Hooper's compensation ranked 2,313th out of 13,032 executives tracked by ExecPay. In other words, Hooper earned more than 82.3% of executives.

ClassificationRankingPercentile
All
2,313
out of 13,032
82nd
Division
Manufacturing
828
out of 4,966
83rd
Major group
Chemicals And Allied Products
257
out of 1,686
85th
Industry group
Drugs
199
out of 1,365
85th
Industry
Pharmaceutical Preparations
164
out of 1,043
84th
Source: SEC filing on June 20, 2017.

Hooper's colleagues

We found five more compensation records of executives who worked with Suzanne Sawochka Hooper at Jazz Pharmaceuticals in 2014.

2014

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2014

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

2014

Matthew Young

Jazz Pharmaceuticals

Chief Financial Officer

2014

Michael Miller

Jazz Pharmaceuticals

Senior Vice President, U.S. Commercial

2014

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

News

You may also like